257 related articles for article (PubMed ID: 8542158)
1. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.
Kharitonov SA; Yates DH; Barnes PJ
Am J Respir Crit Care Med; 1996 Jan; 153(1):454-7. PubMed ID: 8542158
[TBL] [Abstract][Full Text] [Related]
2. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
de Jong JW; van der Mark TW; Koëter GH; Postma DS
Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
[TBL] [Abstract][Full Text] [Related]
3. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
Yates DH; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
[TBL] [Abstract][Full Text] [Related]
4. Effect of short- and long-acting inhaled beta2-agonists on exhaled nitric oxide in asthmatic patients.
Yates DH; Kharitonov SA; Barnes PJ
Eur Respir J; 1997 Jul; 10(7):1483-8. PubMed ID: 9230234
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma.
Kharitonov SA; Donnelly LE; Montuschi P; Corradi M; Collins JV; Barnes PJ
Thorax; 2002 Oct; 57(10):889-96. PubMed ID: 12324677
[TBL] [Abstract][Full Text] [Related]
6. Comparisons of the complementary effect on exhaled nitric oxide of salmeterol vs montelukast in asthmatic children taking regular inhaled budesonide.
Buchvald F; Bisgaard H
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):309-13. PubMed ID: 14533665
[TBL] [Abstract][Full Text] [Related]
7. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid.
Saleh D; Ernst P; Lim S; Barnes PJ; Giaid A
FASEB J; 1998 Aug; 12(11):929-37. PubMed ID: 9707165
[TBL] [Abstract][Full Text] [Related]
8. Changes in sputum eosinophils predict loss of asthma control.
Jatakanon A; Lim S; Barnes PJ
Am J Respir Crit Care Med; 2000 Jan; 161(1):64-72. PubMed ID: 10619799
[TBL] [Abstract][Full Text] [Related]
9. Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone.
Ferreira IM; Hazari MS; Gutierrez C; Zamel N; Chapman KR
Am J Respir Crit Care Med; 2001 Sep; 164(6):1012-5. PubMed ID: 11587988
[TBL] [Abstract][Full Text] [Related]
10. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
[TBL] [Abstract][Full Text] [Related]
11. Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma.
Jatakanon A; Kharitonov S; Lim S; Barnes PJ
Thorax; 1999 Feb; 54(2):108-14. PubMed ID: 10325913
[TBL] [Abstract][Full Text] [Related]
12. Effect of inhaled ciclesonide on airway responsiveness to inhaled AMP, the composition of induced sputum and exhaled nitric oxide in patients with mild asthma.
Kanniess F; Richter K; Böhme S; Jörres RA; Magnussen H
Pulm Pharmacol Ther; 2001; 14(2):141-7. PubMed ID: 11273796
[TBL] [Abstract][Full Text] [Related]
13. Greater effect of inhaled budesonide on adenosine 5'-monophosphate-induced than on sodium-metabisulfite-induced bronchoconstriction in asthma.
O'Connor BJ; Ridge SM; Barnes PJ; Fuller RW
Am Rev Respir Dis; 1992 Sep; 146(3):560-4. PubMed ID: 1519828
[TBL] [Abstract][Full Text] [Related]
14. A dose-dependent effect of the novel inhaled corticosteroid ciclesonide on airway responsiveness to adenosine-5'-monophosphate in asthmatic patients.
Taylor DA; Jensen MW; Kanabar V; Engelstätter R; Steinijans VW; Barnes PJ; O'Connor BJ
Am J Respir Crit Care Med; 1999 Jul; 160(1):237-43. PubMed ID: 10390406
[TBL] [Abstract][Full Text] [Related]
15. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients.
Kharitonov SA; Yates DH; Chung KF; Barnes PJ
Eur Respir J; 1996 Feb; 9(2):196-201. PubMed ID: 8777950
[TBL] [Abstract][Full Text] [Related]
16. Formoterol, montelukast, and budesonide in asthmatic children: effect on lung function and exhaled nitric oxide.
Miraglia del Giudice M; Piacentini GL; Capasso M; Capristo C; Maiello N; Boner AL; Capristo AF
Respir Med; 2007 Aug; 101(8):1809-13. PubMed ID: 17418554
[TBL] [Abstract][Full Text] [Related]
17. Formoterol as needed with or without budesonide in patients with intermittent asthma and raised NO levels in exhaled air: A SOMA study.
Haahtela T; Tamminen K; Malmberg LP; Zetterström O; Karjalainen J; Ylä-Outinen H; Svahn T; Ekström T; Selroos O
Eur Respir J; 2006 Oct; 28(4):748-55. PubMed ID: 17012630
[TBL] [Abstract][Full Text] [Related]
18. Controlled study of linear growth in asthmatic children during treatment with inhaled glucocorticosteroids.
Wolthers OD; Pedersen S
Pediatrics; 1992 May; 89(5 Pt 1):839-42. PubMed ID: 1579391
[TBL] [Abstract][Full Text] [Related]
19. Budesonide but not nedocromil sodium reduces exhaled nitric oxide levels in asthmatic children.
Carrà S; Gagliardi L; Zanconato S; Scollo M; Azzolin N; Zacchello F; Baraldi E
Respir Med; 2001 Sep; 95(9):734-9. PubMed ID: 11575894
[TBL] [Abstract][Full Text] [Related]
20. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma.
Lim S; Jatakanon A; John M; Gilbey T; O'connor BJ; Chung KF; Barnes PJ
Am J Respir Crit Care Med; 1999 Jan; 159(1):22-30. PubMed ID: 9872813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
